Skip to main navigation Skip to search Skip to main content

ZUR PRAVALENZ DES DIABETISCHEN SPATSYNDROMS BEI TYP-1- (IDDM) UND TYPE-II (NIDDM) DIABETES MELLITUS

Translated title of the contribution: Prevalence of diabetic complications of type I and II diabetes mellitus
  • H. P. Hammes
  • , E. Maser
  • , H. Stracke
  • , R. G. Bretzel

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

A retrospective analysis of 575 patients (176 type I and 399 type II diabetic patients) was performed to determine the prevalence of diabetic complications and the relation to metabolic control. Except for persistent proteinuria in type II diabetic patients (prevalence of 38.5% after 5 years of known diabetes duration) there was a clear association between complications and diabetes duration in all patients groups. After 25 years, 71%/46.3% of type I/type II diabetic patients had developed retinopathy, 41.7%/38.9% had persistent proteinuria and 58.3%/57.4% had neuropathy. Patients without complications at the beginning of a retrospective survey period with a mean HbA1 within the lower quartile of the whole group (median 9.0%, 95% confidence interval 8.62%-9.30%) compared to patients with a mean HbA1 within the upper quartile (median 12.95%; 95% CI 12.75%-13.44%) developed significantly less retinopathy (21.1% vs 81.3%; p = 0.001), nephropathy (5.3% vs 31.3%; p = 0.0489) and neuropathy (0% vs 37.5%; p = 0.0004). These results confirm the beneficial effect of long-term good glycemic control on the development of diabetic complications, especially in type II diabetic patients.

Translated title of the contributionPrevalence of diabetic complications of type I and II diabetes mellitus
Original languageGerman
Pages (from-to)67-73
Number of pages7
JournalMedizinische Welt
Volume45
Issue number3
StatePublished - 1994
Externally publishedYes

Keywords

  • HbA1
  • diabetes complications
  • prevalence

Fingerprint

Dive into the research topics of 'Prevalence of diabetic complications of type I and II diabetes mellitus'. Together they form a unique fingerprint.

Cite this